Should You Buy Anthera Pharmaceuticals Inc (ANTH) Following Public Offering Of Common Shares?

In an effort to generate funds for clinical research and development and other general corporate purposes, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced earlier today that it is planning to sell...

Keep Reading →